CHARGED ALPHATMFrontier AI stock research

HNGE · NYSE

Hinge Health, Inc.

Health Information Services · United States

USD 93.16-2.5% daily changeQuote 2026-09-28 · USD
Market cap (USD)
US$7.52B
Trailing P/E
11.33x
Forward P/E
30.47x
Quarterly revenue growth
53.0%
Trailing net margin
15.1%
Indicated dividend yield
—

Snapshot 2026-09-28 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-11-03 (provider estimate, not issuer-confirmed).

Company background

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Company website

Q2 2026

Go beyond the headline.

Hinge Health Stock (HNGE) Q2 2026 Earnings: Revenue +53%, Cost To Serve +15%

Published 2026-08-09

Comparable businesses

HNGE peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricHNGEHinge Health, Inc.Snapshot 2026-09-28Financial period: 2026-06-30HQYHealthEquity, Inc.Snapshot 2026-09-28Financial period: 2026-07-31DOCSDoximity, Inc.Snapshot 2026-09-28Financial period: 2026-06-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$7.52BUS$7.36BUS$4.69BUS$6.02Bn=2
Forward P/EProvider forward earnings estimate30.47x16.18x16.97x16.58xn=2
EV / EBITDAEnterprise value / trailing EBITDA76.58x15.61x19.28x17.44xn=2
Revenue growthLatest quarter vs prior-year quarter53.0%7.6%7.3%7.4%n=2
Operating marginLatest reported quarter19.0%28.4%21.5%25.0%n=2
Free cash flow yieldTrailing cash flow / market cap4.0%5.4%5.1%5.3%n=2
Net debt / EBITDANet debt / trailing EBITDA-4.01x1.39x-3.25x-0.93xn=2
Debt / equityTotal debt / positive book equity0.02x0.49x0.01x0.25xn=2
Trailing P/ETrailing twelve-month earnings11.33x32.13x31.30x31.72xn=2
Price / bookPrice / positive book equity per share21.70x3.71x5.16x4.44xn=2
EV / salesEnterprise value / trailing revenue10.18x5.88x6.13x6.01xn=2
Earnings growthLatest quarter vs prior-year quarter—14.7%-51.9%-18.6%n=2
Gross marginTrailing twelve months84.5%71.2%88.1%79.7%n=2
Net marginTrailing twelve months15.1%17.4%25.5%21.4%n=2
Return on equityProvider trailing return; positive equity only30.4%11.4%17.2%14.3%n=2
Free cash flow marginTrailing free cash flow / revenue41.6%29.2%36.6%32.9%n=2
Dividend yieldIndicated annual dividend / price————
Earnings payoutProvider trailing dividend payout0.0%0.0%0.0%0.0%n=2
Current ratioCurrent assets / current liabilities1.34x2.99x6.08x4.54xn=2
BetaProvider historical market sensitivity—0.231.250.74n=2

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-28. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for HNGE

All available reporting periods
Q2 20262026-08-09

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.